Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for CNMD.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 1997. Start Trial.
Date Value
June 30, 2026 11.57M
March 31, 2026 4.108M
December 31, 2025 -7.111M
September 30, 2025 -5.187M
June 30, 2025 -5.729M
March 31, 2025 -2.929M
December 31, 2024 -4.04M
September 30, 2024 -3.419M
June 30, 2024 -3.59M
March 31, 2024 -2.035M
December 31, 2023 -4.855M
September 30, 2023 -5.394M
June 30, 2023 -5.529M
March 31, 2023 -4.254M
December 31, 2022 -6.318M
September 30, 2022 -91.26M
June 30, 2022 -148.27M
March 31, 2022 -3.687M
December 31, 2021 -3.188M
September 30, 2021 -5.575M
June 30, 2021 -2.994M
March 31, 2021 -3.109M
December 31, 2020 -3.149M
September 30, 2020 -0.06M
June 30, 2020 -3.752M
Date Value
March 31, 2020 -6.677M
December 31, 2019 -8.859M
September 30, 2019 -4.869M
June 30, 2019 -4.984M
March 31, 2019 -368.95M
December 31, 2018 -4.756M
September 30, 2018 -4.46M
June 30, 2018 -3.508M
March 31, 2018 -3.783M
December 31, 2017 -4.628M
September 30, 2017 -17.14M
June 30, 2017 -4.706M
March 31, 2017 -2.584M
December 31, 2016 -4.317M
September 30, 2016 2.409M
June 30, 2016 -4.904M
March 31, 2016 -259.21M
December 31, 2015 -6.78M
September 30, 2015 -3.695M
June 30, 2015 -8.973M
March 31, 2015 -4.914M
December 31, 2014 -7.181M
September 30, 2014 -4.854M
June 30, 2014 -4.576M
March 31, 2014 -4.065M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Stryker Corp. -639.00M
Globus Medical, Inc. -129.05M
Alphatec Holdings, Inc. -22.72M
Baxter International, Inc. -117.00M
Becton, Dickinson & Co. -228.00M